Paraoxonase-1 gene Q192R polymorphism and reactive oxygen metabolites

Journal of International Medical Research

Volumn 40, Issue 4, 2012, Pages 1513-1518

  Kotani, K ^a,b   Tsuzaki, K ^a   Sakane, N ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Diacron reactive oxygen metabolites test (d roms); Japanese; Oxidative stress; Paraoxonase 1 (pon1); Reactive oxygen species

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; DNA; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION;

EID: 84867492447     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/147323001204000431     Document Type: Article

References (26)

1. Aviram M: Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radie Res 2000; 33( suppl): S85 - S97.
2. Rahman K: Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007; 2: 219-236.
3. Humbert R, Adler DA, Disteche CM, et al The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993; 3: 73 - 76.
4. Mackness B, Mackness MI, Arrol S, et al Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol 1997; 122: 265 -268.
5. Aviram M, Rosenblat M, Bisgaier CL, et al Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581 - 1590.
6. Mackness MI, Durrington PN, Mackness B: The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 2004; 4: 211 - 217.
7. Mackness MI, Arrol S, Mackness B, et al Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting lowdensity lipoprotein against lipid peroxidation. Lancet 1997; 349: 851 - 852.
8. Aviram M, Billecke S, Sorenson R, et al Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vase Biol 1998; 18: 1617 - 1624.
9. Mackness B, Mackness MI, Arrol S, et al Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998; 423: 57-60. (Pubitemid 28098579)
10. Bub A, Barth S, Watzl B, et al Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in Rallele-carrier but not in QQ homozygous elderly subjects on a tomato-rich diet. Eur J Nutr 2002; 41: 237 - 243.
11. Baróth A, Németh I, Karg E, et al Roles of paraoxonase and oxidative stress in adolescents with uraemic, essential or obesityinduced hypertension. Kidney Blood Press Res 2006; 29: 144 - 151.
12. Girona J, Manzanares JM, Marimón F, et al Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis 2008; 18: 380 - 387.
13. Van Himbergen T, Roest M, De Waart F, et al Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers. Free Radie Res 2004; 38: 553 - 560.
14. Lee CH, Kamijima M, Kim H, et al 8Hydroxydeoxyguanosine levels in human leukocyte and urine according to exposure to organophosphorus pesticides and paraoxonase 1 genotype. Int Arch Occup Environ Health 2007; 80:217-227. (Pubitemid 46139414)
15. Kuremoto K, Watanabe Y, Ohmura H, et al R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J Atheroscler Thromb 2003; 10: 85 - 92.
16. Agachan B, Yilmaz H, Ergen HA, et al Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidantantioxidant system in Turkish patients with type 2 diabetes mellitus. Physiol Res 2005; 54: 287 - 293.
17. Min J, Park H, Park B, et al Paraoxonase gene polymorphism and vitamin levels during pregnancy: relationship with maternal oxidative stress and neonatal birthweights. Reprod Toxicol 2006; 22: 418 - 424.
18. Aydin M, Gencer M, Cetinkaya Y, et al PON1 55/192 polymorphism, oxidative stress, type, prognosis and severity of stroke. IUBMB Life 2006; 58: 165 - 172.
19. Stephens JW, Khanolkar MP, Bain SC: The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202: 321 - 329.
20. lamele L, Fiocchi R, Vernocchi A: Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 2002; 40: 673 - 676.
21. Vassalle C: An easy and reliable automated method to estimate oxidative stress in the clinical setting. Methods Mol Biol 2008; 477: 31 -39.
22. Cesarone MR, Belcaro G, Carratelli M, et al A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127 - 130.
23. Kotani K, Sakane N: Association between lipoprotein(a) and oxygen reactive metabolite in asymptomatic subjects. Pol Arch Med Wewn 2011; 121: 247-252.
24. 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vase Biol 1997; 17: 3565 - 3569.
25. Imai Y, Monta H, Kurihara H, et al Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 2000; 149: 435 - 442.
26. Mohamed Ali S, Chia SE: Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations - a short review. Ind Health 2008; 46: 309 - 317.